Focus on China edition
China has a population of more than 1 billion people, and stroke incidence and mortality are major contributors to the global burden, hence we thought it prudent to focus on China as a theme in this International Journal of Stroke (IJS) edition. This is particularly pertinent given the role we play as the flagship publication of the World Stroke Organization and its remit to address stroke issues around the globe. We have the important guidelines concerning Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, which should have relevance not only in China but Asia and many other parts of the world as well.
We also have two excellent protocols of important clinical trials to be conducted in China and three interesting reviews. I'm sure that you will enjoy sampling these examples of the high-quality research being undertaken in this region.
Many of you were at the International Stroke Congress in Houston which was of its usual high standard. Several important trials were presented including TARDIS and HEADPOST, both of which had already published their protocols in the IJS.
In TARDIS, the hypothesis that triple antiplatelet therapy might be superior to standard care was tested and, importantly, was not supported. The implication is that attempts to further alter platelet function in acute therapies may not be the way to go, and alternative avenues would need to be explored.
The investigators for the HEADPOST trial used a pragmatic cluster randomised control design to compare the effectiveness of managing patients lying flat or at 30 within 24 h from stroke onset. Again, although there was no difference between the two groups in terms of clinical outcome, this answers an important question, which has puzzled clinicians for more than 100 years.
Our next international gathering will be at the European Stroke Organization Conference in Prague where further important trials will be presented. And we may hear more about the DAWN trial of thrombectomy, up to 24 h, which we hear has been stopped early! For HEADPOST SAP, see http://journals.sagepub. com/doi/full/10.1177/1747493016674955
For HEADPOST Protocol, see http://journals.sagepub.com/doi/full/10.1177/1747493015620808
For TARDIS SAP, see http://journals.sagepub.com/ doi/full/10.1111/ijs.12445
For TARDIS Protocol, see http://journals.sagepub. com/doi/full/10.1111/ijs.12538
